10/07/2026
A technology developed to help scientists study the brain is now helping researchers explore new possibilities for cancer treatment.
This week, Peter Hegemann, PhD, of Humboldt University in Berlin, and Georg Nagel, PhD, of the University of Würzburg, received the in Physiology or Medicine for discoveries that enabled optogenetics—a technique for controlling cells with light.
Their work began as a way to better understand the brain. Since then, optogenetics has found applications well beyond neuroscience, including cancer research.
At Texas A&M Health, bioengineer Yubin Zhou, MD, PhD, is using light-sensitive molecular switches to control CAR T cells, activating their cancer-killing activity with light-emitting nanoparticles. In animal models, the approach helped reduce some side effects associated with CAR T-cell therapy.
It’s an early proof of concept, but it shows how foundational discoveries can travel across fields and open new possibilities for treating disease. Learn more: tx.ag/NanoOpto